United States · 
Who invested in NeuMoDx Molecular?
NeuMoDx Molecular's investors include Pfizer, Baird Capital, Arboretum Ventures and Wolverine Venture Fund.
20142015201620172018
$21MSeries B$20MVenture
United States · Venture startup
Who invested in NeuMoDx Molecular
Funding summaryUpdated 26 Oct 2026
$41Mraised across 2 rounds since 2014, from 2 sources
$21MSeries B$20MVenture
- Latest round
- Venture, $20MMay 2018
- Biggest round
- $21MSeries B · Apr 2014
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $21M Apr 2014
- Biggest round
- $21M Series B · Apr 2014
- Between rounds
- 4.1 years from the last two
The rounds
- May 2018Venture$20M
No investor was named in the report.
Source recordedSEC filing: $20M sold, first sale Apr 2018
- Apr 2014Series B$21M4 new
From a historical funding recordSEC filing: $11M sold, first sale Mar 2014
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about NeuMoDx Molecular
How much has NeuMoDx Molecular raised?
NeuMoDx Molecular has raised $41M across 2 rounds since 2014.
When did NeuMoDx Molecular last raise?
NeuMoDx Molecular's most recent round was a Venture of $20M in May 2018.
What was NeuMoDx Molecular's biggest round?
NeuMoDx Molecular's largest round on record is $21M (Series B), in Apr 2014.
Who backed NeuMoDx Molecular first?
NeuMoDx Molecular's first round on record, in Apr 2014, was backed by Pfizer, Baird Capital and Arboretum Ventures and 1 others.
What stage is NeuMoDx Molecular at?
NeuMoDx Molecular's latest named round is a Venture, in May 2018.
Where is NeuMoDx Molecular based?
NeuMoDx Molecular is based in the United States.
Companies like NeuMoDx Molecular
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.